Discover investment opportunities in Top 30 Stocks Under $12 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $12 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 30 Stocks Under $12 using our Smart AI Filter.
10 stocks found for "Top 30 Stocks Under $12"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.76 | ±96.1% | -12.0 | 0.00% | |||
1.17 | ±100.0% | -4.1 | 0.00% | |||
0.65 | ±52.7% | 7.9 | 4.57% | |||
2.28 | ±93.4% | -775.0 | 0.00% | |||
1.40 | ±59.3% | -45.5 | 0.00% | |||
1.52 | ±52.4% | 12.2 | 0.13% | |||
1.73 | ±64.4% | 28.8 | 0.00% | |||
0.79 | ±46.9% | -62.2 | 0.00% | |||
1.63 | ±92.7% | -155.0 | 0.00% | |||
1.12 | ±67.2% | 8.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Read moreatai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Read moreThe mean of analysts' price targets for Trevi Therapeutics (TRVI) points to a 231.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read moreQ: What makes ATAI Life Sciences a potentially attractive investment at its current price level?
A: ATAI Life Sciences, a biotechnology company, focuses on mental health treatment innovations, often appealing to investors interested in high-growth potential within the pharmaceutical sector. Due to its exploratory R&D and partnerships with other biotech firms, it may attract speculative investments despite inherent volatility.
Q: Is VNET Group's current price reflective of its growth potential in the Chinese data center market?
A: VNET Group, providing carrier-neutral data center services in China, aligns with growing demand for digital infrastructure. Its pricing under $12 might highlight either competitive market pressures or an opportunity in China's expanding tech sector contingent on broader economic conditions.
Q: How do market conditions affect Coeur Mining's (CDE) appeal to value investors?
A: CDE's performance is closely tied to gold and silver prices due to its mining operations. Current market prices may appeal to value investors betting on commodity price increases or improved operational efficiency in volatile metal markets.
Q: Why could investors be interested in Rocket Lab USA (RKLB) at this stock price?
A: Rocket Lab USA, a key player in the aerospace sector, specifically in satellite launches, might attract investors focused on the growing space industry. Its innovative small satellite technology could present growth opportunities despite current pricing pressures.
Q: What risks should investors consider with Uranium Energy Corp (UEC) in the current economic climate?
A: UEC's focus on uranium exploration and production makes it sensitive to energy market shifts and nuclear power policies. While nuclear energy is increasingly seen as a clean energy alternative, regulatory and demand fluctuations pose significant risks.
Q: How does Denison Mines Corp (DNN) fit into an energy-focused investment strategy?
A: As a uranium mining company, DNN aligns with long-term energy transition strategies focusing on nuclear power. Investors might find its pricing attractive if they foresee increased uranium demand driven by global clean energy initiatives.